Male Infertility Pipeline Study, 2024: Insights on Key Products FE 999049, APBR2, AZD5904, PKB-171, IGX12, and Leflutrozole
May 08, 2024 06:17 ET
|
Research and Markets
Dublin, May 08, 2024 (GLOBE NEWSWIRE) -- The "Male Infertility - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Femasys Expands Commercial Management Team with Addition of Experienced New Hires
May 07, 2024 08:30 ET
|
Femasys Inc.
ATLANTA, May 07, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
Global Surrogacy Market Poised for Remarkable Growth, Projected to Reach US$ 306.9 Million by 2032 Driven by Technological Innovations and Growing Receptiveness Toward Gestational Surrogacy
May 01, 2024 10:41 ET
|
Research and Markets
Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Surrogacy Market Report by Type (Gestational Surrogacy, Traditional Surrogacy), Technology (IVF with ICSI, IVF without ICSI, Intrauterine Insemination),...
In Vitro Fertilization Market To Reach USD 44.7 Billion By 2032 | DataHorizzon Research
April 15, 2024 03:00 ET
|
DataHorizzon Research
Fort Collins, Colorado, April 15, 2024 (GLOBE NEWSWIRE) -- The market for IVF treatments is expected to experience growth in the forecast period, driven by increasing technological advancements...
Global In Vitro Fertilization Market Expected to Reach USD 52.68 Billion by 2034 with a Steady CAGR of 6.92%
March 27, 2024 08:24 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global In Vitro Fertilization Market Analysis & Forecast 2024-2034: Market By Product; By Type; By Procedure Type; By End-user; and By Region"...
Femasys Invites Investors to View Fireside Chat Today, March 21, 2024, to Discuss the Infertility Treatment Landscape
March 21, 2024 09:00 ET
|
Femasys Inc.
ATLANTA, March 21, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing the significant unmet needs of women worldwide with a broad portfolio of...
Femasys Announces Positive Topline Data from Pivotal Trial for its FDA-Cleared FemaSeed® for the Treatment of Infertility
March 20, 2024 08:15 ET
|
Femasys Inc.
-- In the severe male factor cohort, findings show 24% of women became pregnant after FemaSeed -- -- FemaSeed pregnancy rate by cycle was more than double historic intrauterine insemination (IUI)...
Infertility Treatments Market Size Expected to Reach USD 3.28 Bn by 2033
March 18, 2024 11:00 ET
|
Precedence Research
Ottawa, March 18, 2024 (GLOBE NEWSWIRE) -- The global infertility treatments market size was valued at USD 1.58 billion in 2023 and is projected to hit around USD 2.96 billion by 2032, a study...
[Latest] Global mHealth Market Size/Share Worth USD 374.6 Billion by 2032 at a 17.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
March 14, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, March 14, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “mHealth Market Size, Trends and Insights By Device Type (Cardiac Monitors,...
Femasys to Participate in Fireside Chat to Discuss the Infertility Treatment Landscape on March 21, 2024
March 13, 2024 09:00 ET
|
Femasys Inc.
-- CEO Kathy Lee-Sepsick and Chief Medical Officer James Liu to Join Jones Trading Analyst Catherine Novack in a Conversation on Current Treatment Options in Infertility Including FemaSeed® at 1PM ET...